C-MER MEDICAL (Stock Code: 03309) Announces Turnaround with Estimated HK$90.00–110.00 Million Profit

Bulletin Express03-06

C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity holders of between HK$90.00 million and HK$110.00 million, reversing the HK$135.20 million loss recorded in 2024.

According to the company, revenue in 2025 slightly increased to approximately HK$1,947.00 million from HK$1,913.20 million in the previous year. Management attributed this turnaround to optimized service network strategies, including the closure of underperforming operations, and the absence of a material impairment loss on non-current assets, compared to the HK$197.70 million impairment loss recorded in 2024.

The company stated that these figures are based on preliminary management accounts and have not yet been audited or reviewed by its auditors or audit committee. The final annual results announcement is expected to be published by the end of March 2026. Investors are advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1171171551?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1171171551","market":"us","top_or_hot":-1,"title":"C-MER MEDICAL (Stock Code: 03309) Announces Turnaround with Estimated HK$90.00–110.00 Million Profit","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity holders of between HK$90.00 million and HK$110.00 million, reversing the HK$135.20 million loss recorded in 2024.</p>\n<p>According to the company, revenue in 2025 slightly increased to approximately HK$1,947.00 million from HK$1,913.20 million in the previous year. Management attributed this turnaround to optimized service network strategies, including the closure of underperforming operations, and the absence of a material impairment loss on non-current assets, compared to the HK$197.70 million impairment loss recorded in 2024.</p>\n<p>The company stated that these figures are based on preliminary management accounts and have not yet been audited or reviewed by its auditors or audit committee. The final annual results announcement is expected to be published by the end of March 2026. Investors are advised to exercise caution when dealing in the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER MEDICAL (Stock Code: 03309) Announces Turnaround with Estimated HK$90.00–110.00 Million Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER MEDICAL (Stock Code: 03309) Announces Turnaround with Estimated HK$90.00–110.00 Million Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity holders of between HK$90.00 million and HK$110.00 million, reversing the HK$135.20 million loss recorded in 2024.</p>\n<p>According to the company, revenue in 2025 slightly increased to approximately HK$1,947.00 million from HK$1,913.20 million in the previous year. Management attributed this turnaround to optimized service network strategies, including the closure of underperforming operations, and the absence of a material impairment loss on non-current assets, compared to the HK$197.70 million impairment loss recorded in 2024.</p>\n<p>The company stated that these figures are based on preliminary management accounts and have not yet been audited or reviewed by its auditors or audit committee. The final annual results announcement is expected to be published by the end of March 2026. Investors are advised to exercise caution when dealing in the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1171171551","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1171171551","pubTimestamp":1772789059,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER MEDICAL（股份代号：03309）宣布扭亏为盈，预计盈利90.00-110.00百万港元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited (the “Group”) announced a turnaround in its financial performance for the year ended 31 December 2025. The Group expects to record a profit attributable to equity holders of between HK$90.00 million and HK$110.00 million, reversing the HK$135.20 million loss recorded in 2024.\nAccording to the company, revenue in 2025 slightly increased to approximately HK$1,947.00 million from HK$1,913.20 million in the previous year. Management attributed this turnaround to optimized service network strategies, including the closure of underperforming operations, and the absence of a material impairment loss on non-current assets, compared to the HK$197.70 million impairment loss recorded in 2024.\nThe company stated that these figures are based on preliminary management accounts and have not yet been audited or reviewed by its auditors or audit committee. The final annual results announcement is expected to be published by the end of March 2026. Investors are advised to exercise caution when dealing in the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1171171551","isCrawlerRequest":true}